Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Michelle Joanne, PhD

Methods Lead
Pfizer Inc.

Poster(s):

(351) Preliminary Findings from a Feasibility and Capacity Assessment of Truveta® Studio using Flu Vaccine as Example: A Near Real-Time Electronic Health Records Database with Potential to Monitor Post-Approval Vaccine Safety

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST